Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study

Journal of the American College of Cardiology

Volumn 64, Issue 13, 2014, Pages 1339-1348

  Meredith Am, Ian T ^a   Walters, Darren L ^b   Dumonteil, Nicolas ^c   Worthley, Stephen G ^d   Tchétché, Didier ^e   Manoharan, Ganesh ^f   Blackman, Daniel J ^g   Rioufol, Gilles ^h   Hildick Smith, David ⁱ   Whitbourn, Robert J ^j   Lefèvre, Thierry ^k   Lange, Rüdiger ^l   Müller, Ralf ^m   Redwood, Simon ⁿ   Allocco, Dominic J ^o   Dawkins, Keith D ^o  

^a MONASH UNIVERSITY   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c CHU RANGUEIL   (France)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e CLINIQUE PASTEUR   (France)

^f ROYAL VICTORIA HOSPITAL   (United Kingdom)

^g LEEDS GENERAL INFIRMARY   (United Kingdom)

^h LOUIS PRADEL HOSPITAL   (France)

ⁱ Worthing Hospital   (United Kingdom)

^j ST VINCENT S HOSPITAL   (Australia)

^k Institut Cardiovasculaire   (France)

^l TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^m Heart Center Siegburg   (Germany)

ⁿ GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^o BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

aortic regurgitation; aortic valve stenosis; TAVR; transfemoral

Indexed keywords

ABSENCE OF COMPLICATIONS; AGED; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DISEASE SEVERITY; EQUIPMENT DESIGN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS AORTIC VALVE; PRESSURE GRADIENT; PROSPECTIVE STUDY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VERY ELDERLY; CALCINOSIS; CLINICAL TRIAL; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RISK; TAVR; TRANSFEMORAL;

AORTIC REGURGITATION; AORTIC VALVE STENOSIS; TAVR; TRANSFEMORAL;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; EQUIPMENT DESIGN; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 84908286773     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.05.067     Document Type: Article

References (54)

1. R.O. Bonow, B.A. Carabello, and K. Chatterjee 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 2008 e1 e142
2. A. Vahanian, O. Alfieri, and F. Andreotti Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 33 2012 2451 2496
3. B. Iung, A. Cachier, and G. Baron Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26 2005 2714 2720
4. P. Varadarajan, N. Kapoor, and R.C. Bansal Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis Ann Thorac Surg 82 2006 2111 2115
5. I. Ben-Dor, D. Dvir, and I.M. Barbash Outcomes of patients with severe aortic stenosis at high surgical risk evaluated in a trial of transcatheter aortic valve implantation Am J Cardiol 110 2012 1008 1014
6. M.A. Clark, S.V. Arnold, and F.G. Duhay Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis Circ Cardiovasc Qual Outcomes 5 2012 697 704
7. M.B. Leon, C.R. Smith, M. Mack for the PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
8. J.J. Popma, D.H. Adams, M.J. Reardon for the CoreValve United States Clinical Investigators Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery J Am Coll Cardiol 63 2014 1972 1981
9. C.R. Smith, M.B. Leon, M.J. Mack for the PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
10. D.H. Adams, J.J. Popma, M.J. Reardon for the U.S. CoreValve Clinical Investigators Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
11. R.R. Makkar, G.P. Fontana, H. Jilaihawi for the PARTNER Trial Investigators Transcatheter aortic-valve replacement for inoperable severe aortic stenosis N Engl J Med 366 2012 1696 1704
12. S.K. Kodali, M.R. Williams, C.R. Smith for the PARTNER Trial Investigators Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
13. S. Geisbüsch, S. Bleiziffer, and D. Mazzitelli Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation Circ Cardiovasc Interv 3 2010 531 536
14. D. John, L. Buellesfeld, and S. Yuecel Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis J Am Coll Cardiol Intv 3 2010 233 243
15. S.H. Ewe, A.C. Ng, and J.D. Schuijf Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation Am J Cardiol 108 2011 1470 1477
16. C. Tamburino, D. Capodanno, and A. Ramondo Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis Circulation 123 2011 299 308
17. M. Abdel-Wahab, R. Zahn, M. Horack for the German Transcatheter Aortic Valve Interventions Registry Investigators Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome: results from the German transcatheter aortic valve interventions registry Heart 97 2011 899 906
18. J.M. Sinning, M. Vasa-Nicotera, and D. Chin Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement J Am Coll Cardiol 62 2013 11 20
19. I.T. Meredith, K.L. Hood, N. Haratani, D.J. Allocco, and K.D. Dawkins Boston Scientific Lotus valve EuroIntervention 8 Suppl Q 2012 Q70 Q74
20. I.T. Meredith, S.G. Worthley, and R.J. Whitbourn Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study EuroIntervention 9 2014 1264 1270
21. S.M. O'Brien, D.M. Shahian, G. Filardo for the Society of Thoracic Surgeons Quality measurement Task Force The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2: isolated valve surgery Ann Thorac Surg 88 2009 S23 S42
22. J. Afilalo, K.P. Alexander, and M.J. Mack Frailty assessment in the cardiovascular care of older adults J Am Coll Cardiol 63 2014 767-62
23. R. Gooley, S. Lockwood, P. Antonis, and I.T. Meredith The SADRA Lotus Valve System: a fully repositionable, retrievable prosthesis Minerva Cardioangiol 61 2013 45 52
24. R. Gooley, P. Antonis, and I.T. Meredith The next era of transcatheter aortic valve replacement: a case illustrating the benefit of a fully re-positionable, re-sheathable and retrievable prosthesis Catheter Cardiovasc Interv 83 2014 831 835
25. M.B. Leon, N. Piazza, and E. Nikolsky Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
26. A.P. Kappetein, S.J. Head, and P. Généreux Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
27. J.E. Ware Jr., M. Kosinski, and S.D. Keller A 12-item Short-Form Health Survey: construction of scales and preliminary test of reliability and validity Med Care 34 1996 220 223
28. EuroQol Group EuroQol: a new facility for the measurement of health-related quality of life Health Policy 16 1990 199 208
29. J.G. Webb, M. Chandavimol, and C.R. Thompson Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
30. E. Grube, J.C. Laborde, and U. Gerckens Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study Circulation 114 2006 1616 1624
31. N. Piazza, E. Grube, and U. Gerckens Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
32. M. Thielmann, D. Wendt, and H. Eggebrecht Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement Ann Thorac Surg 88 2009 1468 1474
33. J. Ye, A. Cheung, and S.V. Lichtenstein Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients J Thorac Cardiovasc Surg 137 2009 167 173
34. P. Chodór, K. Wilczek, and R. Przybylski Immediate and 6-month outcomes of transapical and transfemoral Edwards-Sapien prosthesis implantation in patients with aortic stenosis Kardiol Pol 68 2010 1124 1131
35. J. Rodés-Cabau, J.G. Webb, and A. Cheung Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol 55 2010 1080 1090
36. R. Dworakowski, P.A. MacCarthy, and M. Monaghan Transcatheter aortic valve implantation for severe aortic stenosis: a new paradigm for multidisciplinary intervention: a prospective cohort study Am Heart J 160 2010 237 243
37. H. Eltchaninoff, A. Prat, M. Gilard for the FRANCE Registry Investigators Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry Eur Heart J 32 2011 191 197
38. K. Kim, and D.L. DeMets Design and analysis of group sequential tests based on the type I error spending rate function Biometrika 74 1987 149 154
39. S.A. Nashef, F. Roques, and L.D. Sharples EuroSCORE II Eur J Cardiothorac Surg 41 2012 734 744
40. N. Dumonteil, I.T. Meredith, and D.L. Walters Need for permanent pacemaker following implantation of the repositionable second-generation LOTUS device for transcatheter aortic valve replacement: results from the pivotal REPRISE II trial (abstr) J Am Coll Cardiol 62 2013 B39
41. P. Généreux, S.J. Head, and N.M. Van Mieghem Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies J Am Coll Cardiol 59 2012 2317 2326
42. G.P. Ussia, M. Barbanti, A.S. Petronio for the CoreValve Italian Registry Investigators Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis Eur Heart J 33 2012 969 976
43. A. Chieffo, G.L. Buchanan, and N.M. Van Mieghem Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration) J Am Coll Cardiol 61 2013 830 836
44. M. Abdel-Wahab, J. Mehilli, C. Frerker for the CHOICE Investigators Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial JAMA 311 2014 1503 1514
45. N.E. Moat, P. Ludman, and M.A. de Belder Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry J Am Coll Cardiol 58 2011 2130 2138
46. R. Zahn, U. Gerckens, E. Grube on behalf of the German Transcatheter Aortic Valve Interventions-Registry Investigators Transcatheter aortic valve implantation: first results from a multi-centre real-world registry Eur Heart J 32 2011 198 204
47. M. Gilard, H. Eltchaninoff, B. Iung for the FRANCE 2 Investigators Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med 366 2012 1705 1715
48. P. Pibarot, N. Weissman, and W. Stewart Reduced incidence of prosthesis-patient mismatch and its sequelae in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER Trial Cohort A analysis (abstr) J Am Coll Cardiol 61 2013 E1865
49. J.G. Webb, and D.A. Wood Current status of transcatheter aortic valve replacement J Am Coll Cardiol 60 2012 483 492
50. M. Gotzmann, M. Lindstaedt, and A. Mügge From pressure overload to volume overload: aortic regurgitation after transcatheter aortic valve implantation Am Heart J 163 2012 903 911
51. J. Schofer, A. Colombo, and S. Klugmann Prospective multicenter evaluation of the Direct Flow Medical transcatheter aortic valve J Am Coll Cardiol 63 2014 763 768
52. L. Buellesfeld, S. Stortecky, and D. Heg Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation J Am Coll Cardiol 60 2012 493 501
53. M. Urena, J.G. Webb, and C. Tamburino Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function Circulation 129 2014 1233 1243
54. N. Piazza, R.J. Nuis, and A. Tzikas Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation EuroIntervention 6 2010 475 484